Table 1:

Patient characteristics in the spatial transcriptomics versus flow cytometry cohort.

	Spatial Transcriptomics	Flow Cytometry
	N = 12	N = 11
Median age: years (IQR)	70 (63-77)	71 (65-74)
Female Sex	5 (42%)	5 (45%)
Race
Caucasian	8 (67%)	10 (91%)
Asian	3 (25%)	1 (9%)
Black	0 (0%)	0 (0%)
Unidentified	1 (8%)	0 (0%)
Operation
Whipple	9 (75%)	5 (45%)
Distal Pancreatectomy	2 (17%)	5 (45%)
Other	1 (8%)	1 (9%)
Median Lesion Size, cm	5.2	3.8
Branch Type
Main Branch	5 (42%)	4 (36%)
Side Branch	3 (25%)	4 (36%)
Mixed	4 (33%)	3 (27%)
Histology Subset
Intestinal	6 (50%)	2 (18%)
Pancreatobiliary	6 (50%)	5 (45%)
Gastric	0 (0%)	4 (36%)
Cancer Present within Lesion	4 (33%)	5 (45%)
Cancer Stage if Applicable	IA (2), IIA (2)	IA (1), IB (1), IIA (1), IIB (2)
Median Follow up Length, months	27	24
Cancer Recurrence	2 (50%)	3 (60%)
Death	3 (25%)	0 (0%)